Lack of Functional Benefit with Glutamine versus Placebo in Duchenne Muscular Dystrophy: A Randomized Crossover Trial

Elise Mok, Guy Letellier, Jean-Marie Cuisset et al. · 2009

Read Lack of Functional Benefit with Glutamine versus Placebo in Duchenne Muscular Dystrophy: A Randomized Crossover Trial by Elise Mok, Guy Letellier, Jean-Marie Cuisset et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005448.txt.

Description

Elise Mok and colleagues ran a drug trial for boys with Duchenne muscular dystrophy, reported in PLOS ONE in 2009. Boys with the disease lose muscle strength over time. The amino acid glutamine, taken by mouth, had been shown to slow the breakdown of protein in the whole body.

In the trial, boys took glutamine and a dummy treatment in turn, without knowing which was which. After months of treatment, the team checked walking and other daily functions. Glutamine gave no clear gain in function over the dummy treatment. That honest result helps families avoid false hope and guides care toward what works.

Catalog record

CREATORElise Mok, Guy Letellier, Jean-Marie Cuisset et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005448

Browse the full library · About the Tower of Babel